The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Open accessAbstract
Background—: The rate of ischemic stroke associated with traditional risk factors for patients with atrial fibrillation has declined over the past 2 decades. Furthermore, new and potentially safer anticoagulants are on the horizon. Thus, the balance between risk factors for stroke and benefit of anticoagulation may be shifting. Methods and Results—: The Markov state transition decision model was used to analyze the CHADS 2 score, above which anticoagulation is preferred, first using the stroke rate predicted for the CHADS 2 derivation cohort, and then using the stroke rate from the more contemporary AnTicoagulation and Risk Factors In Atrial Fibrillation cohort for any CHADS 2 score. The base case was a 69-year-old man with atrial fibrillation. Interventions included oral anticoagulant therapy with warfarin or a hypothetical “new and safer” anticoagulant (based on dabigatran), no antithrombotic therapy, or aspirin. Warfarin is preferred above a stroke rate of 1.7% per year, whereas aspirin is preferred at lower rates of stroke. Anticoagulation with warfarin is preferred even for a score of 0 using the higher rates of the older CHADS 2 derivation cohort. Using more contemporary and lower estimates of stroke risk raises the threshold for use of warfarin to a CHADS 2 score ≥2. However, anticoagulation with a “new, safer” agent, modeled on the results of the Randomized Evaluation of Long-Term Anticoagulation Therapy trial of dabigatran, leads to a lowering of the threshold for anticoagulation to a stroke rate of 0.9% per year. Conclusions—: Use of a more contemporary estimate of stroke risk shifts the “tipping point,” such that anticoagulation is preferred at a higher CHADS 2 score, reducing the number of patients for whom anticoagulation is recommended. The introduction of “new, safer” agents, however, would shift the tipping point in the opposite direction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,158
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Rothwell, P., Coull, A., Giles, M., Howard, S., Silver, L., Bull, L., Gutnikov, S., Edwards, P., Mant, D., Sackley, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16405-2 · Cited by 1,094
Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Self-citationAntithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., Koudstaal, P. J., Chang, Y., & Hellemons, B. (2002) · JAMA · doi:10.1001/jama.288.19.2441 · Cited by 714
Self-citationGo, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 703
Self-citationThe Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Singer, D. E., Chang, Y., Fang, M. C., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., & Go, A. S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00003 · Cited by 656
Self-citationThe Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
Rosand, J., Eckman, M. H., Knudsen, K. A., Singer, D. E., & Greenberg, S. M. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.8.880 · Cited by 616
Self-citationThe Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy
Greenberg, S. M., William Rebeck, G., Vonsattel, J. P. G., Gomez‐Isla, T., & Hyman, B. T. (1995) · Annals of Neurology · doi:10.1002/ana.410380219 · Cited by 541
Self-citationOral Anticoagulants and Intracranial Hemorrhage: Facts and Hypotheses
Hart, R. G., Boop, B. S., & Anderson, D. C. (1995) · Stroke · doi:10.1161/01.str.26.8.1471 · Cited by 541
Fang, M. C., Chang, Y., Hylek, E. M., Rosand, J., Greenberg, S. M., Go, A. S., & Singer, D. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00005 · Cited by 532
Self-citationDeath and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages
Fang, M. C., Go, A. S., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.034 · Cited by 510
Self-citationApolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
O'Donnell, H. C., Rosand, J., Knudsen, K. A., Furie, K. L., Segal, A. Z., Chiu, R. I., Ikeda, D., & Greenberg, S. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420403 · Cited by 501
Self-citationThe increasing incidence of anticoagulant-associated intracerebral hemorrhage
Flaherty, M. L., Kissela, B., Woo, D., Kleindorfer, D., Alwell, K., Sekar, P., Moomaw, C. J., Haverbusch, M., & Broderick, J. P. (2007) · Neurology · doi:10.1212/01.wnl.0000250340.05202.8b · Cited by 482
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-1 · Cited by 477
Woo, D., Sauerbeck, L. R., Kissela, B. M., Khoury, J. C., Szaflarski, J. P., Gebel, J., Shukla, R., Pancioli, A. M., Jauch, E. C., Menon, A. G., et al. (2002) · Stroke · doi:10.1161/01.str.0000014774.88027.22 · Cited by 419
The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life
Gage, B. F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.16.1829 · Cited by 370
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L., Pomernacki, N. K., & Singer, D. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.065 · Cited by 312
Self-citationWarfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study
Rosand, J., Hylek, E. M., O’Donnell, H. C., & Greenberg, S. M. (2000) · Neurology · doi:10.1212/wnl.55.7.947 · Cited by 305
Self-citationBleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Fan, Y. H., Zhang, L., Lam, W. W. M., Mok, V. C. T., & Wong, K. S. (2003) · Stroke · doi:10.1161/01.str.0000090841.90286.81 · Cited by 254
Fang, M. C., Go, A. S., Hylek, E. M., Chang, Y., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00828.x · Cited by 249
Self-citationLakshminarayan, K., Solid, C. A., Collins, A. J., Anderson, D. C., & Herzog, C. A. (2006) · Stroke · doi:10.1161/01.str.0000230607.07928.17 · Cited by 243
Sherman, D. G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1185 · Cited by 231
The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study
Wintzen, A. R., de Jonge, H., Loeliger, E. A., & Bots, G. T. A. M. (1984) · Annals of Neurology · doi:10.1002/ana.410160505 · Cited by 214
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke
Smith, E. E., Rosand, J., Knudsen, K. A., Hylek, E. M., & Greenberg, S. M. (2002) · Neurology · doi:10.1212/wnl.59.2.193 · Cited by 196
Self-citationRisk of Hemorrhagic Stroke With Aspirin Use: An Update
Gorelick, P. B., & Weisman, S. M. (2005) · Stroke · doi:10.1161/01.str.0000174189.81153.85 · Cited by 169
Effect of hypertension on anticoagulated patients with atrial fibrillation
Lip, G. Y. H., Frison, L., Grind, M., & on behalf of the SPORTIF Investigators (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl504 · Cited by 168
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320143013 · Cited by 161
Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages
Wong, K. S., Chan, E., Liu, J., Gao, S., & Lam, W. W. M. (2003) · Neurology · doi:10.1212/01.wnl.0000046583.40125.20 · Cited by 155
Singer, D. E., Chang, Y., Fang, M. C., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Go, A. S. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.830232 · Cited by 121
Self-citationArima, H., Hart, R. G., Colman, S., Chalmers, J. P., Anderson, C. S., Rodgers, A., Woodward, M., MacMahon, S. W., & Neal, B. C. (2005) · Stroke · doi:10.1161/01.str.0000181115.59173.42 · Cited by 115
APOE genotype, ethnicity, and the risk of cerebral hemorrhage
Tzourio, C., Arima, H., Harrap, S. B., Anderson, C. S., Godin, O., Woodward, M., Neal, B. C., Bousser, M., Chalmers, J. P., Cambien, F., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000308819.43401.87 · Cited by 113
Genetic Risk for Ischemic and Hemorrhagic Stroke
Yamada, Y., Metoki, N., Yoshida, H., Satoh, K., Ichihara, S., Kato, K., Kameyama, T., Yokoi, K., Matsuo, H., Segawa, T., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229694.97827.38 · Cited by 105
Woo, D., Kaushal, R. D., Chakraborty, R., Woo, J. G., Haverbusch, M. A., Sekar, P., D, B. M. K. M., Pancioli, A., Jauch, E. C., Kleindorfer, D., et al. (2005) · Stroke · doi:10.1161/01.str.0000177891.15082.b9 · Cited by 82
Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation
Hart, R. G., & Pearce, L. A. (2009) · Stroke · doi:10.1161/strokeaha.109.549428 · Cited by 74
Prognosis for Survival After an Initial Stroke
Lai, S. M., Alter, M., Friday, G. H., et al. (1995) · Stroke · doi:10.1161/01.str.26.11.2011 · Cited by 73
Stroke severity in patients with atrial fibrillation
Penado, S., Cano, M. P., Acha, O., Hernández, J. L., & Riancho, J. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01063-x · Cited by 22
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Self-citationFriberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr488 · Cited by 1,192
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Metadata
- Authors
- Eckman, M. H., Singer, D. E., Rosand, J., & Greenberg, S. M.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 14-21
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- OpenAlex
- W2546446487
- Cited by
- 275
- References
- 53
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.